RenThyroid
NDC 64950-180, LEVOTHYROXINE and LIOTHYRONINE, tablet, from Genus Lifesciences.
- Product NDC
- 64950-180
- Status
- Listed
- Labeler
- Genus Lifesciences
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64950-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVOTHYROXINE47.5 ug/1
- LIOTHYRONINE11.25 ug/1
Pharmacologic classes
Thyroxine [CS]; Triiodothyronine [CS]; l-Thyroxine [EPC]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64950-180-01 | 64950018001 | 100 TABLET in 1 BOTTLE (64950-180-01) |
| 64950-180-09 | 64950018009 | 90 TABLET in 1 BOTTLE (64950-180-09) |
| 64950-180-14 | 64950018014 | 14 TABLET in 1 BOTTLE (64950-180-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f0c1875-7706-43ec-a9ef-ad82a49e46ec
Use it
Look up 64950-180 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64950-180 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64950-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.